Ask AI
ProCE Banner Series

CAR T-Cell Therapy in Community and Shared-Care Settings: Practical Strategies to Manage Delayed and Long-term Toxicities

Attend these workshops led by expert oncology nurses to learn how to identify, mitigate, and coordinate care for delayed and long-term toxicities after CAR T-cell therapy, including experiences in CAR T-cell survivorship, community transition, patient and caregiver education, symptom triage, and post–CAR T-cell therapy toxicity management.

  ANCC with Pharmacotherapy Credit
Who Should Attend

This activity is intended for community oncology nurses, nurse practitioners, clinical nurse specialists, and other healthcare professionals who care for patients treated with CAR T-cell therapies.

All Events

CAR T-Cell Therapy in Community and Shared-Care Settings: Practical Strategies to Manage Delayed and Long-term Toxicities

Upcoming Events

November

07

2026

12:45 PM - 1:45 PM Central Time (CT)

Virtual

SIMULCAST | Host Group TX, Houston, Texas

Topics

CAR-T Adverse Event Management Strategies

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to strengthen learners’ knowledge, confidence, and competence in recognizing, mitigating, and managing delayed and long-term toxicities after CAR T-cell therapy, with emphasis on patient and caregiver education, symptom triage, timely escalation, and shared-care coordination between cellular therapy centers and community oncology practices. 

Target Audience
This activity is intended for community oncology nurses, nurse practitioners, clinical nurse specialists, and other healthcare professionals who care for patients treated with CAR T-cell therapies.

Learning Objectives
Upon completion of this event, participants should be able to:

  • Risk-stratify patients receiving CD19- or BCMA-directed CAR T-cell therapy for delayed and long-term toxicities, including prolonged/recurrent cytopenias, infection, hypogammaglobulinemia, delayed neurologic toxicity, HLH/MAS, immune effector cell–associated enterocolitis, and secondary malignancies
  • Differentiate expected post–CAR T-cell recovery from red-flag symptoms or laboratory findings that require urgent evaluation, referral, or re-escalation to the cellular therapy center
  • Apply evidence-informed strategies for post–CAR T-cell therapy monitoring, infection prevention, vaccination counseling, IVIG referral, symptom triage, patient/caregiver education, and documentation
  • Develop a shared-care transition plan that specifies monitoring responsibilities, escalation triggers, emergency department handoff guidance, patient/caregiver education, and communication pathways between the cellular therapy center and community oncology team

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour, including 1.0 hour of pharmacotherapy credit.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by educational grants from Bristol Myers Squibb and Johnson & Johnson.

Bristol Myers Squibb

Johnson & Johnson

For customer support please click here.

Mailing Address:

 

Decera Clinical
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191